Anja van Biezen
Overview
Explore the profile of Anja van Biezen including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
68
Citations
1590
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Chabannon C, Ruggeri A, Montoto S, van Biezen A, van der Werf S, Markslag A, et al.
Best Pract Res Clin Haematol
. 2024 Aug;
37(2):101557.
PMID: 39098799
The European society for Blood and Marrow Transplantation (EBMT) has a long-standing interest in the evaluation of hematopoietic cell transplantation. More than three decades ago, its members established a continental...
2.
Beelen D, Iacobelli S, Koster L, Eikema D, van Biezen A, Stolzel F, et al.
Bone Marrow Transplant
. 2024 Feb;
59(5):670-679.
PMID: 38383713
A randomized study (acronym: MC-FludT.14/L Trial II) demonstrated that fludarabine plus treosulfan (30 g/m²) was an effective and well tolerated conditioning regimen for allogeneic hematopoietic cell transplantation (allo-HCT) in older...
3.
Styczynski J, Tridello G, Koster L, Knelange N, Wendel L, van Biezen A, et al.
Bone Marrow Transplant
. 2023 May;
58(8):881-892.
PMID: 37149673
We previously analyzed trends in incidence and factors associated with lethal complications in ALL/AML/CML patients (causes of deaths; COD-1 study). The objective of this study was the analysis of incidence...
4.
Waszczuk-Gajda A, Penack O, Sbianchi G, Koster L, Blaise D, Remenyi P, et al.
J Clin Med
. 2022 Jun;
11(12).
PMID: 35743620
Background: The main goal of this post hoc analysis of the Collaboration to Collect Autologous Transplant Outcomes in Lymphoma and Myeloma (CALM) study was to evaluate the rate of short-...
5.
Ruggeri L, Eikema D, Bondanza A, Noviello M, van Biezen A, de Wreede L, et al.
Transplant Cell Ther
. 2022 Jan;
28(4):206.e1-206.e6.
PMID: 35017118
Transplacental trafficking of maternal and fetal cells during pregnancy establishes long-term reciprocal microchimerism in both mother and child. Consequently, the maternal immune system may become sensitized to paternal histocompatibility antigens....
6.
Schetelig J, Hoek J, Stilgenbauer S, Middeke J, Andersen N, Fox C, et al.
Bone Marrow Transplant
. 2021 Nov;
57(1):144.
PMID: 34773090
No abstract available.
7.
Ruggeri L, Vago L, Eikema D, de Wreede L, Ciceri F, Diaz M, et al.
Bone Marrow Transplant
. 2021 Mar;
56(8):1900-1907.
PMID: 33767404
Human leukocyte antigen (HLA) class-I mismatches that trigger donor-versus-recipient natural killer (NK)-cell alloreactivity reduce the incidence of leukemia relapse and improve survival of acute myeloid leukemia patients after T-cell-depleted HLA-haplotype...
8.
Schetelig J, Hoek J, Stilgenbauer S, Middeke J, Andersen N, Fox C, et al.
Bone Marrow Transplant
. 2020 Aug;
56(3):692-695.
PMID: 32801318
No abstract available.
9.
Salooja N, Greinix H, Ruutu T, van der Werf S, van Biezen A, Lawitschka A, et al.
Biol Blood Marrow Transplant
. 2020 Jul;
26(10):1955-1962.
PMID: 32623077
Reduced bone mineral density (BMD) is a well-recognized complication of hematopoietic cell transplantation (HCT), with significant drops in BMD occurring within the first 12 months after HCT. Guidance on identifying...
10.
Hayden P, Iacobelli S, Perez-Simon J, van Biezen A, Minnema M, Niittyvuopio R, et al.
Eur J Haematol
. 2019 Nov;
104(3):181-189.
PMID: 31737951
Objectives: The aim of this study was to compare the effect of the intensity of conditioning approaches used in allogeneic transplantation in myeloma-reduced intensity conditioning (RIC), non-myeloablative (NMA), myeloablative conditioning...